ALCIDION GROUP LIMITED — Capital/Financing Update 2021

Apr 14, 2021

==> picture [132 x 35] intentionally omitted <==

15 April 2021

Australian Securities Exchange 20 Bridge Street Sydney NSW 2000

Alcidion and consortium partners selected as preferred provider for Department of Defence contract

• Alcidion, as part of a Consortium, has been selected as the preferred provider for a major healthcare IT project to capture data and support clinical decision making across the Australian Defence Force

• Alcidion will provide the Longitudinal Health Record via its Miya Precision product

• Potential value of contract to Alcidion of approximately $21M over 5.5 years

• Subject to final negotiations and Commonwealth funding approvals, final contracts expected in calendar Q4 2021

Melbourne, Australia: Alcidion Group Limited (ASX:ALC) today advises that it is a member of the consortium (the Consortium) selected as the preferred provider for an enterprise Healthcare Knowledge Management (HKM) System for the Department of Defence of the Australian Government (Defence).

Defence’s HKM project seeks to deliver a system that records, stores, aggregates and analyses health information for the Defence population. The HKM will capture and manage health data and information across Defence's healthcare continuum and will unify multidisciplinary primary and occupational care, with emergency and hospital care in both garrison and deployed domains; enabling better clinical decision making at the point of care to empower a true joint health effect.

The Consortium is led by a global IT and engineering consulting firm with clients across multiple sectors in government, including Defence. It involves several other digital health partners, many of them leading Australian digital health providers, to provide the full system requirements.

Alcidion will provide the Longitudinal Health Record via its Miya Precision product, aggregating the data from Consortium partners and other systems in the Defence environment to support the HKM solution.

The value of Alcidion’s contract for Stage 1 and 2 of the project is estimated to be approximately $21M over 5.5 years (68 months). This phase will cover implementation and a subscription to the Miya Precision platform.

The prime contract negotiations are currently being finalised between the Consortium lead and the Commonwealth of Australia. Upon finalisation of the prime contract, Alcidion’s sub-contract will be finalised.

Project commencement is planned for calendar Q4 2021 and will be subject to final Government approvals for the funding and solution.

Managing Director and CEO Kate Quirke said: “Alcidion is looking forward to working with the HKM project team to bring the negotiations to a successful conclusion so we may start this exciting and significant project for Defence.”

END

Alcidion Group Limited | Level 10 9 Yarra Street SOUTH YARRA VIC 3141 |+61 3 8060 6177 | www.alcidion.com

==> picture [88 x 24] intentionally omitted <==

For further information, please contact:

Kyahn Williamson

WE Communications Ph: +61 401 018 828 kwilliamson@we-worldwide.com

About Alcidion

Alcidion Limited (ASX:ALC) has a simple purpose: to transform healthcare with smart, intuitive technology solutions that meet the needs of hospital and allied healthcare, worldwide. It offers a complementary set of software products and services that create a unique offering in the global healthcare market; solutions that support interoperability, allow communication and task management, and deliver clinical decision support at the point of care to improve patient outcomes. In 2017 Alcidion acquired Oncall System and its Smartpage clinical communication system. In 2018 it acquired the Patientrack bedside patient monitoring software and MKM Health, an IT solutions and services provider. These offerings now operate under the Alcidion brand. With over 25 years of combined healthcare experience, Alcidion brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

www.alcidion.com

© Alcidion Group Limited 2020. Alcidion, Miya Precision, Patientrack and Smartpage are registered trademarks. All other brands and product names and trademarks are the registered property of their respective companies.

This announcement is authorised for release by the Board of Directors of Alcidion Limited.

Page 2 of 2